Drug
Paracetamol (drug)
Paracetamol (drug) is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
25%
Ph phase_1
2
50%
Ph phase_4
1
25%
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 41 (25.0%)
Trials by Status
not_yet_recruiting125%
enrolling_by_invitation125%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingphase_4
Pain Control During ESWL Using Non-Opioid Analgesics
NCT07512297
enrolling_by_invitationphase_2
Prophylactic IV Paracetamol in Extremely Premature Infants
NCT07067177
completedphase_1
Paracetamol and Pharmacogenetic
NCT01520792
completedphase_1
Visualisation of the Central Analgesic Effect of Paracetamol in Functional MRI
NCT01562704
Clinical Trials (4)
Showing 4 of 4 trials
NCT07512297Phase 4
Pain Control During ESWL Using Non-Opioid Analgesics
NCT07067177Phase 2
Prophylactic IV Paracetamol in Extremely Premature Infants
NCT01520792Phase 1
Paracetamol and Pharmacogenetic
NCT01562704Phase 1
Visualisation of the Central Analgesic Effect of Paracetamol in Functional MRI
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4